Osteotech and BioHorizons previously entered into an agreement for BioHorizons to distribute Osteotech’s products to the US dental market in 2000.
Sam Owusu-Akyaw, Osteotech’s president and CEO, said: “We believe our bone regeneration products are the perfect solution for the new bone grafting procedures being developed to replace missing or extracted teeth with dental implants or as support for dentures, crowns and bridges.”